| The first coronavirus treatment to protect people with mild illness from developing severe disease was granted emergency use authorization by regulators Monday evening. The drug, a laboratory-brewed antibody drug that imitates the immune system's attack on the virus, is made by Eli Lilly & Co., but the initial scarcity of the drug and the logistical complexities of administering it could mute its immediate impact on the pandemic. | 
No comments:
Post a Comment